Inventor · disambiguated record
Chenkou Wei
Also filed as: WEI CHENKOU
19 granted patents·11 pending applications·269 citations·filing 1988–2022
93Inventor score
Files withBRISTOL MYERS SQUIBB CO12WEI CHENKOU3GOUGOUTAS JACK Z2LI JUN2AMERICAN TELEPHONE & TELEGRAPH1
Top patents by PatentIndex Score
30 records- 0194US6031004ASalts of metformin and methodBRISTOL MYERS SQUIBB CO·Filed 1999·Granted Feb 29, 2000·125 cites·24 claims
- 0290US6302958B1Sonic impinging jet crystallization apparatus and processBRISTOL MYERS SQUIBB CO·Filed 2000·Granted Oct 16, 2001·41 cites·17 claims
- 0388US8759372B2N-(5S,6S,9R)-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-ctclohepta[b]Pyridin-9-yl-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-carboxylate saltBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jun 24, 2014·17 cites·8 claims
- 0484US7943656B2Crystal forms of saxagliptin and processes for preparing sameBRISTOL MYERS SQUIBB CO·Filed 2008·Granted May 17, 2011·8 cites·46 claims
- 0582US7381737B2Crystalline forms and process for preparing spiro-hydantoin compoundsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Jun 3, 2008·8 cites·60 claims
- 0681US7008959B2Form of irbesartan, processes for obtaining the said and pharmaceutical compositions containing itSANOFI AVENTIS·Filed 2004·Granted Mar 7, 2006·17 cites·34 claims
- 0774US8236847B2Crystal forms of saxagliptin and processes for preparing sameGOUGOUTAS JACK Z·Filed 2011·Granted Aug 7, 2012·3 cites·31 claims
- 0874US6800761B1Form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing sameSANOFI SYNTHELABO·Filed 1999·Granted Oct 5, 2004·34 cites·6 claims
- 0967US7829711B2Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-C]pyridine-3-yl]-ethane-1,2-dioneBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Nov 9, 2010·0 cites·6 claims
- 1063US8119658B2Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitorsLI JUN·Filed 2008·Granted Feb 21, 2012·0 cites·20 claims
- 1162US4915716AFabrication of lightguide soot preformsAMERICAN TELEPHONE & TELEGRAPH·Filed 1988·Granted Apr 10, 1990·15 cites·6 claims
- 1262US2016318904A1Substituted tetrahydroisoquinoline compounds as factor xia inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Application pending·0 cites
- 1360US8901106B2Imidazole prodrug LXR modulatorsKICK ELLEN K·Filed 2012·Granted Dec 2, 2014·1 cites·14 claims
- 1458US9173879B2Crystalline forms of (S)-7-([1,2,4]triazolo[1,5-a ]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline and use thereofBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Nov 3, 2015·0 cites·14 claims
- 1557US8802715B2Crystal forms of saxagliptin and processes for preparing sameASTRAZENECA AB·Filed 2013·Granted Aug 12, 2014·0 cites·19 claims
- 1654US2024368130A1Crystal forms of 6-(cyclopropanecarboxamido)-4-((2-methoxy-3- (1-methyl-1h-1,2,4-triazol-3-yl)phenyl)amino)-n-(methyl-d3) pyridazine-3-carboxamideBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 1753US2008269499A1Crystalline forms and process for preparing spiro-hydantoin compoundsBRISTOL MYERS SQUIBB CO·Filed 2008·Application pending·0 cites
- 1853US2006100432A1Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dioneMATISKELLA JOHN D·Filed 2005·Application pending·0 cites
- 1952US2012283181A1Crystal forms of saxagliptin and processes for preparing sameGOUGOUTAS JACK Z·Filed 2012·Application pending·0 cites
- 2052US2004185110A1Formulations of low solubility bioactive agents and processes for making the sameFiled 2003·Application pending·0 cites
- 2152US2024190845A1Crystal forms of 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1h-1,2,4-triazol-3-yl)phenyl)amino)-n-(methyl-d3)pyridazine-3-carboxamideBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 2251US9920034B2Crystalline forms of a factor XIa inhibitorBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Mar 20, 2018·0 cites·19 claims
- 2349US8063208B2Crystalline forms of (3R,4R)-4-amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-olWEI CHENKOU·Filed 2007·Granted Nov 22, 2011·0 cites·22 claims
- 2447US8541444B2Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitorsLI JUN·Filed 2011·Granted Sep 24, 2013·0 cites·20 claims
- 2546US2006160841A1Crystallization via high-shear transformationWEI CHENKOU·Filed 2005·Application pending·0 cites
- 2640US2004005257A1Crystallization system using homogenizationFiled 2003·Application pending·0 cites
- 2739US8815894B2Crystalline forms of (S)-7-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline and use thereofWEI CHENKOU·Filed 2010·Granted Aug 26, 2014·0 cites·16 claims
- 2837US2005256314A1Process employing controlled crystallization in forming crystals of a pharmaceuticalKIM SOOJIN·Filed 2005·Application pending·0 cites
- 2934US2004005256A1Crystallization system utilizing atomizationFiled 2003·Application pending·0 cites
- 3029US8691981B2Crystalline forms of (S)-1-(4-(5-cyclopropyl-1H-pyrazol-3-ylamino)pyrrolo[1,2-f][1,2,4]triazin-2-yl)-N-(6-fluoropyridin-3-yl)-2-methylpyrrolidine-2-carboxamideSCHLAM ROXANA·Filed 2011·Granted Apr 8, 2014·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Chenkou Wei files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →